Dr Anna Kirby

Dr Anna Kirby, Consultant Clinical Oncologist and Reader, The Royal Marsden NHS Foundation Trust & Institute of Cancer Research Dr Anna Kirby is a Consultant Clinical Oncologist specialising in the treatment of patients with breast cancer. She leads research into novel breast radiotherapy techniques at The Royal Marsden and Institute of Cancer Research, London. She is Chief Investigator of FAST-Forward Boost, Technical Radiotherapy Lead for the PARABLE Proton Trial, Chief Clinical Co-Ordinator for the IMPORT breast radiotherapy trials and Breast Lead on the CORE trial evaluating the role of stereotactic radiotherapy in treating metastatic disease. Dr Kirby graduated from Cambridge University in 1995 with a first-class honours degree in Medicine and Psychology. Her specialist oncology training was completed at The Royal Marsden and Guy's and St Thomas' Hospitals following which she undertook a research degree at the Institute of Cancer Research. Her publications describe methods for improving the accuracy of breast cancer radiotherapy and for reducing late side-effects of treatment including heart disease. Alongside colleagues, her work in heart-sparing breast radiotherapy, partial breast radiotherapy and simultaneous integrated boost treatment has changed international practice. Dr Kirby was President of the European Society of Radiation Oncology (ESTRO) from 2022-24 and remains a member of the ESTRO Board.

Radiotherapy for breast cancer Partial breast irradiation Stereotactic radiotherapy